
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inflammation and fibrosis in murine models of heart failure
Lucas Bacmeister, Michael Schwarzl, Svenja Warnke, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 3
Closed Access | Times Cited: 317
Lucas Bacmeister, Michael Schwarzl, Svenja Warnke, et al.
Basic Research in Cardiology (2019) Vol. 114, Iss. 3
Closed Access | Times Cited: 317
Showing 1-25 of 317 citing articles:
New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury
Jin Wang, Sam Toan, Hao Zhou
Angiogenesis (2020) Vol. 23, Iss. 3, pp. 299-314
Closed Access | Times Cited: 269
Jin Wang, Sam Toan, Hao Zhou
Angiogenesis (2020) Vol. 23, Iss. 3, pp. 299-314
Closed Access | Times Cited: 269
Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission
Jin Wang, Pingjun Zhu, Ruibin Li, et al.
Redox Biology (2019) Vol. 30, pp. 101415-101415
Open Access | Times Cited: 185
Jin Wang, Pingjun Zhu, Ruibin Li, et al.
Redox Biology (2019) Vol. 30, pp. 101415-101415
Open Access | Times Cited: 185
Resolving the intertwining of inflammation and fibrosis in human heart failure at single-cell level
Man Rao, Xiliang Wang, Guangran Guo, et al.
Basic Research in Cardiology (2021) Vol. 116, Iss. 1
Closed Access | Times Cited: 140
Man Rao, Xiliang Wang, Guangran Guo, et al.
Basic Research in Cardiology (2021) Vol. 116, Iss. 1
Closed Access | Times Cited: 140
The Role of Interleukin-6 Family Members in Cardiovascular Diseases
Yongqi Feng, Di Ye, Zhen Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 74
Yongqi Feng, Di Ye, Zhen Wang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 74
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Runkai Chen, Hongrui Zhang, Botao Tang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Targeting MAPK-ERK/JNK pathway: A potential intervention mechanism of myocardial fibrosis in heart failure
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116413-116413
Open Access | Times Cited: 20
Zeyu Zhang, Zhihua Yang, Shuai Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116413-116413
Open Access | Times Cited: 20
Flavonoids: Potential therapeutic agents for cardiovascular disease
Yingxue Liu, Jing Luo, Peng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32563-e32563
Open Access | Times Cited: 15
Yingxue Liu, Jing Luo, Peng Lin, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32563-e32563
Open Access | Times Cited: 15
SERCA Overexpression Improves Mitochondrial Quality Control and Attenuates Cardiac Microvascular Ischemia-Reperfusion Injury
Ying Tan, David Mui, Sam Toan, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 696-707
Open Access | Times Cited: 123
Ying Tan, David Mui, Sam Toan, et al.
Molecular Therapy — Nucleic Acids (2020) Vol. 22, pp. 696-707
Open Access | Times Cited: 123
BET Epigenetic Reader Proteins in Cardiovascular Transcriptional Programs
Patrícia Cristine Borck, Lian‐Wang Guo, Jorge Plutzky
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1190-1208
Open Access | Times Cited: 119
Patrícia Cristine Borck, Lian‐Wang Guo, Jorge Plutzky
Circulation Research (2020) Vol. 126, Iss. 9, pp. 1190-1208
Open Access | Times Cited: 119
Upregulation of Circular RNA CircNFIB Attenuates Cardiac Fibrosis by Sponging miR-433
Yujiao Zhu, Wen Pan, Tingting Yang, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 101
Yujiao Zhu, Wen Pan, Tingting Yang, et al.
Frontiers in Genetics (2019) Vol. 10
Open Access | Times Cited: 101
Pathological Roles of Mitochondrial Oxidative Stress and Mitochondrial Dynamics in Cardiac Microvascular Ischemia/Reperfusion Injury
Hao Zhou, Sam Toan
Biomolecules (2020) Vol. 10, Iss. 1, pp. 85-85
Open Access | Times Cited: 101
Hao Zhou, Sam Toan
Biomolecules (2020) Vol. 10, Iss. 1, pp. 85-85
Open Access | Times Cited: 101
Silencing of METTL3 attenuates cardiac fibrosis induced by myocardial infarction via inhibiting the activation of cardiac fibroblasts
Tingting Li, Yuting Zhuang, Wanqi Yang, et al.
The FASEB Journal (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 97
Tingting Li, Yuting Zhuang, Wanqi Yang, et al.
The FASEB Journal (2020) Vol. 35, Iss. 2
Closed Access | Times Cited: 97
Irisin activates Opa1-induced mitophagy to protect cardiomyocytes against apoptosis following myocardial infarction
Ting Xin, Chengzhi Lu
Aging (2020) Vol. 12, Iss. 5, pp. 4474-4488
Open Access | Times Cited: 86
Ting Xin, Chengzhi Lu
Aging (2020) Vol. 12, Iss. 5, pp. 4474-4488
Open Access | Times Cited: 86
SIRT5‐Related Desuccinylation Modification Contributes to Quercetin‐Induced Protection against Heart Failure and High‐Glucose‐Prompted Cardiomyocytes Injured through Regulation of Mitochondrial Quality Surveillance
Xing Chang, Tian Zhang, Junyan Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 72
Xing Chang, Tian Zhang, Junyan Wang, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 72
[Retracted] Alleviation of Inflammation and Oxidative Stress in Pressure Overload‐Induced Cardiac Remodeling and Heart Failure via IL‐6/STAT3 Inhibition by Raloxifene
Shengqi Huo, Wei Shi, Haiyan Ma, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 70
Shengqi Huo, Wei Shi, Haiyan Ma, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 70
Dapagliflozin: a sodium–glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling
Yuze Zhang, Xiaoyan Lin, Yong Chu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Yuze Zhang, Xiaoyan Lin, Yong Chu, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models
Minru Liao, Qiang Xie, Yuqian Zhao, et al.
Pharmacological Research (2022) Vol. 176, pp. 106077-106077
Closed Access | Times Cited: 57
Minru Liao, Qiang Xie, Yuqian Zhao, et al.
Pharmacological Research (2022) Vol. 176, pp. 106077-106077
Closed Access | Times Cited: 57
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Cuncun Hua, Xinming Liu, Lirong Liang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 55
Cuncun Hua, Xinming Liu, Lirong Liang, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 55
Based on network pharmacology and in vitro experiments to prove the effective inhibition of myocardial fibrosis by Buyang Huanwu decoction
Tianyue Wang, Xinyu Jiang, Yanmin Ruan, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13767-13783
Open Access | Times Cited: 50
Tianyue Wang, Xinyu Jiang, Yanmin Ruan, et al.
Bioengineered (2022) Vol. 13, Iss. 5, pp. 13767-13783
Open Access | Times Cited: 50
Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 48
Guang‐Hong Chen, Honglin Xu, Tong Xu, et al.
Phytomedicine (2022) Vol. 104, pp. 154277-154277
Closed Access | Times Cited: 48
Panaxatriol saponin ameliorates myocardial infarction-induced cardiac fibrosis by targeting Keap1/Nrf2 to regulate oxidative stress and inhibit cardiac-fibroblast activation and proliferation
Huan Yao, Qingman He, Cong Huang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 264-275
Closed Access | Times Cited: 44
Huan Yao, Qingman He, Cong Huang, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 264-275
Closed Access | Times Cited: 44
Traditional Chinese Medicine Ginseng Dingzhi Decoction Ameliorates Myocardial Fibrosis and High Glucose-Induced Cardiomyocyte Injury by Regulating Intestinal Flora and Mitochondrial Dysfunction
Junyan Wang, Peiwen Chen, Qiuyu Cao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-33
Open Access | Times Cited: 43
Junyan Wang, Peiwen Chen, Qiuyu Cao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-33
Open Access | Times Cited: 43
Calycosin as a Novel PI3K Activator Reduces Inflammation and Fibrosis in Heart Failure Through AKT–IKK/STAT3 Axis
Xiaoping Wang, Weili Li, Yawen Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Xiaoping Wang, Weili Li, Yawen Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 40
Role of emodin in atherosclerosis and other cardiovascular diseases: Pharmacological effects, mechanisms, and potential therapeutic target as a phytochemical
Xinyue Wang, Shengjie Yang, Yujuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114539-114539
Open Access | Times Cited: 23
Xinyue Wang, Shengjie Yang, Yujuan Li, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114539-114539
Open Access | Times Cited: 23
Pharmacological properties of Polygonatum and its active ingredients for the prevention and treatment of cardiovascular diseases
Hongyuan Lin, Wenhui Wang, Mengqi Peng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 14
Hongyuan Lin, Wenhui Wang, Mengqi Peng, et al.
Chinese Medicine (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 14